Arena Pharmaceuticals
HOME CONTACT US SITE MAP
 
Lorcaserin Published in New England Journal of Medicine
Read about the lorcaserin Phase 3 BLOOM trial in the New England Journal of Medicine.
Lorcaserin for Weight Management
Our most advanced drug candidate, lorcaserin, is for weight management, including weight loss and maintenance of weight loss.
Pipeline
Pipeline of novel and selective drug candidates developed independently and with collaborators.
Investors
Arena will be the recognized world leader in GPCR drug discovery and development.
Press Releases
More...

2009 Annual Stockholders Meeting
Annual Report 2009 Annual Report (PDF)
2010 Proxy Statement (PDF)

If you do not have Adobe® Reader, download it here. It is available without charge from Adobe®. Arena is not responsible for the content of this linked page.
 

This page last updated 7/9/2010
Additional Information regarding Arena is available in its SEC filings
© Copyright 2000-2010 Arena Pharmaceuticals, Inc.
All Rights Reserverd
Terms and Conditions
Privacy Statement

ABOUT US PRODUCT CANDIDATES RESEARCH PROGRAMS GPCR TECHNOLOGY INVESTORS CAREERS